This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cytopia Research Pty Ltd. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Isabelle Lucet
Introduction
Isabelle Lucet is a prominent inventor based in Glen Waverley, Australia. She has made significant contributions to the field of biochemistry, particularly in the study of Janus Kinase 2 (JAK2). Her work has implications for understanding and treating diseases associated with JAK2 activity.
Latest Patents
Isabelle Lucet holds a patent for the "Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof." This invention focuses on X-ray crystallography studies of the JAK2 domain. It details the crystal structure of a JAK2 kinase domain bound to an inhibitor. The patent also discusses the use of this structural information to select and screen for compounds that interact with JAK2 and related proteins. This research is crucial for developing treatments for diseases mediated by inappropriate JAK2 activity. She has 1 patent to her name.
Career Highlights
Isabelle is associated with Cytopia Research Pty Ltd, where she continues her innovative work. Her research has contributed to advancements in understanding the molecular mechanisms of JAK2, which is vital for developing targeted therapies.
Collaborations
Isabelle has collaborated with notable scientists, including Andrew Frederick Wilks and Christopher John Burns. These collaborations have enhanced her research and expanded the impact of her findings in the scientific community.
Conclusion
Isabelle Lucet's contributions to the field of biochemistry, particularly through her patent on JAK2, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also paves the way for potential therapeutic developments.